Invisible Populations: The Need for Race and Ethnicity Data in Cancer Control
JCO Global Oncology · 2025-04 · (11)
DOI: 10.1200/go-25-00049 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2025-04. Verfasst von Mei Ling Yap und 9 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Unlocking the power of health equity demands acknowledging a stark truth: race and ethnicity matter in cancer control planning.The current absence of robust and carefully analyzed race and ethnicity data is a form of discrimination, hindering delivery of effective and equitable cancer care worldwide. The Importance of Race and Ethnicity Data Collection in Cancer ControlSystematic collection and reporting of data on racial and ethnic disparities are imperative in cancer care.People from minoritized populations experience barriers across the cancer care continuum including in accessing screening, 1 early diagnosis, 2 treatment, 3 and survivorship 4 and palliative care 5 because of structural and systemic racism resulting in culturally incongruent health systems, where there is a lack of agency and cultural safety (Table 1).Consequently, survival 10 and toxicities 7 vary substantially according to race, as do financial toxicity 9 and caregiver burden.11 Compounding this, people from minoritized racial backgrounds encounter intersectional challenges related to sex, sexual orientation, and geographical and socioeconomic circumstances.Adopting a color-blind approach in the formulation of cancer control policies counterintuitively perpetuates prevailing disparities, eliminating opportunities to identify at-risk populations, tailor screening programs, and ensure culturally safe navigation across the cancer care continuum.Similarly, disregarding race and ethnicity in research may exclude minoritized racial and ethnic populations, leading to biased findings and limited applicability.Clinical trials in high-income countries consistently lead to recommendations and funded interventions that are overfitted to White participants and do not meet the needs of minoritized groups.12 Collection and reporting of data on race and ethnicity are also relevant but are often neglected in low-and middle-income countries (LMICs).For example, in the Caribbean, the paucity of electronic health records and a scarcity of cancer registries obstruct the acquisition of cancer data stratified by race and ethnicity.13 Socioeconomic and structural inequities also directly affect cancer outcomes, underscoring the need for comprehensive, disaggregated data to guide interventions.In instances where race and ethnicity data are available, such data can be used to inform targeted initiatives.A recent example is data from the Hotan province of China, where 33% of cancer diagnoses in its Uygur population were cervical cancer, 6 demonstrating the need for screening centers, access to vaccination, and treatment facilities.The urgency of supporting the collection, analysis, and reporting of data on race and ethnicity in health care has been illustrated by the observation that COVID-19 disease disproportionately affected people from minoritized racial groups, triggering the formation of the US Health Equity Taskforce.A clear understanding of risk exposure, diagnostic processes, treatment decisions, and living with cancer in minoritized racial and ethnic populations is vital to plan how to best prevent, diagnose, and manage specific populations, including during health and humanitarian crises.
Autor:innen und Institutionen
- The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
- The Collaboration for Cancer Outcomes, Research and Evaluation (CCORE), Ingham Institute, UNSW Sydney, Liverpool, NSW, Australia.
- Liverpool and Macarthur cancer Therapy Centres, Western Sydney University, Sydney, NSW, Australia.
- Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
- Centre for Health Economics Research and Evaluation (CHERE), UTS, Sydney, NSW, Australia.
ORCID-Profile: Mei Ling Yap, Nirmala Bhoo-Pathy, Beverley M Essue, Maryam Naghsh-Nejad, Otuto Amarauche Chukwu, Jennifer Moodley, Dingle Spence
Zitieren
APA
Yap, M. L., Bhoo-Pathy, N., Essue, B. M., Naghsh-Nejad, M., Batumalai, V., Chukwu, O. A., Dowe, K., Moodley, J., Spence, D., & Stanaway, F. F. (2025). Invisible Populations: The Need for Race and Ethnicity Data in Cancer Control. JCO Global Oncology. https://doi.org/10.1200/go-25-00049
Vancouver
Yap ML, Bhoo-Pathy N, Essue BM, Naghsh-Nejad M, Batumalai V, Chukwu OA, et al. Invisible Populations: The Need for Race and Ethnicity Data in Cancer Control. JCO Global Oncology. 2025. doi:10.1200/go-25-00049
BibTeX
@article{Yap2025,
author = {Yap, Mei Ling and Bhoo-Pathy, Nirmala and Essue, Beverley M and Naghsh-Nejad, Maryam and Batumalai, Vikneswary and Chukwu, Otuto Amarauche and Dowe, Kapel and Moodley, Jennifer and Spence, Dingle and Stanaway, Fiona F},
title = {Invisible Populations: The Need for Race and Ethnicity Data in Cancer Control},
journal = {JCO Global Oncology},
year = {2025},
number = {11},
doi = {10.1200/go-25-00049}
}
EUVIMED